Efficacy of tezepelumab according to age at asthma onset in NAVIGATOR
G. Brusselle (Ghent, Belgium), J. Spahn (Wilmington, United States), G. Hunter (Cambridge, United Kingdom), N. Martin (Leicester, United Kingdom), J. Llanos-Ackert (Thousand Oaks, United States), S. Ponnarambil (Cambridge, United Kingdom)
Source: International Congress 2022 – Translational studies of asthma and COPD
Session: Translational studies of asthma and COPD
Session type: Thematic Poster
Number: 4315
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Brusselle (Ghent, Belgium), J. Spahn (Wilmington, United States), G. Hunter (Cambridge, United Kingdom), N. Martin (Leicester, United Kingdom), J. Llanos-Ackert (Thousand Oaks, United States), S. Ponnarambil (Cambridge, United Kingdom). Efficacy of tezepelumab according to age at asthma onset in NAVIGATOR. 4315
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|